KMT2A and acute myeloid leukemia: In India, a country with similar demographics, a large scale analysis of the cytogenetic profile of patients with de novo acute myeloid leukemia showed that 15% had t (8; 21), 9% had t (15; 17), 8% had 8+, 6% had −7/del 7q, 5% had KMT2A rearrangements, 4.4% had inv (16)/t (16/16), 3% had −5/del 5q, 2% has −17/abn17p and 1.5% had inv (3) in order of decreasing frequency (Amare et al., 2016).